Kendall Morrison

1.5k total citations
20 papers, 397 citations indexed

About

Kendall Morrison is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Kendall Morrison has authored 20 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Kendall Morrison's work include Boron Compounds in Chemistry (6 papers), Nuclear Physics and Applications (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Kendall Morrison is often cited by papers focused on Boron Compounds in Chemistry (6 papers), Nuclear Physics and Applications (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Kendall Morrison collaborates with scholars based in United States, Japan and France. Kendall Morrison's co-authors include Arthur Raitano, Pia M. Challita-Eid, Karen Morrison, Zili An, Jean Gudas, Fuyuhiko Tamanoi, Aya Jakobovits, Steven B. Kanner, Kotaro Matsumoto and Juan J. Pérez‐Villar and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Kendall Morrison

18 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kendall Morrison United States 10 119 89 87 87 76 20 397
Dennis Doleschel Germany 11 169 1.4× 148 1.7× 58 0.7× 101 1.2× 67 0.9× 17 678
Mary‐Keara Boss United States 11 161 1.4× 142 1.6× 205 2.4× 98 1.1× 77 1.0× 41 616
Gaurav Malviya Italy 16 173 1.5× 162 1.8× 75 0.9× 184 2.1× 82 1.1× 34 620
Fernando López‐Campos Spain 10 184 1.5× 74 0.8× 174 2.0× 94 1.1× 83 1.1× 61 441
Xiumei Ma China 12 124 1.0× 181 2.0× 110 1.3× 34 0.4× 91 1.2× 34 473
Nobuhiko Kanaya Japan 11 232 1.9× 149 1.7× 123 1.4× 29 0.3× 90 1.2× 57 503
Marion M. Deken Netherlands 12 143 1.2× 79 0.9× 111 1.3× 69 0.8× 74 1.0× 18 446
Toru Tamai Japan 11 103 0.9× 61 0.7× 156 1.8× 65 0.7× 172 2.3× 17 783
Denis Beckford-Vera United States 14 139 1.2× 112 1.3× 73 0.8× 264 3.0× 23 0.3× 31 468
Le-Cun Xu United States 8 246 2.1× 226 2.5× 63 0.7× 172 2.0× 28 0.4× 12 608

Countries citing papers authored by Kendall Morrison

Since Specialization
Citations

This map shows the geographic impact of Kendall Morrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kendall Morrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kendall Morrison more than expected).

Fields of papers citing papers by Kendall Morrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kendall Morrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kendall Morrison. The network helps show where Kendall Morrison may publish in the future.

Co-authorship network of co-authors of Kendall Morrison

This figure shows the co-authorship network connecting the top 25 collaborators of Kendall Morrison. A scholar is included among the top collaborators of Kendall Morrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kendall Morrison. Kendall Morrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raitano, Arthur, W Kilby, Karen Morrison, et al.. (2025). Exploratory Rat Toxicology and Efficacy of the Boron Neutron Capture Therapy Drug Boronotyrosine in a Mouse Model of Head and Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 123(5). 1395–1400.
2.
3.
Raitano, Arthur, Chunying Zhang, Linnette Capo, et al.. (2023). Boronotyrosine, a Borylated Amino Acid Mimetic with Enhanced Solubility, Tumor Boron Delivery, and Retention for the Re-emerging Boron Neutron Capture Therapy Field. Journal of Medicinal Chemistry. 66(19). 13809–13820. 18 indexed citations
4.
Bright, Scott J., et al.. (2022). Effect of boron compounds on the biological effectiveness of proton therapy. Medical Physics. 49(9). 6098–6109. 9 indexed citations
5.
6.
Tamanoi, Fuyuhiko, Shanmugavel Chinnathambi, Takushi Takata, et al.. (2021). Construction of Boronophenylalanine-Loaded Biodegradable Periodic Mesoporous Organosilica Nanoparticles for BNCT Cancer Therapy. International Journal of Molecular Sciences. 22(5). 2251–2251. 27 indexed citations
7.
Dat, Ngoc Xuan, Kotaro Matsumoto, Hanh Kieu Thi Ta, et al.. (2020). Biodegradable Periodic Mesoporous Organosilica (BPMO) Loaded with Daunorubicin: A Promising Nanoparticle‐Based Anticancer Drug. ChemMedChem. 15(7). 593–599. 41 indexed citations
8.
Doñate, Fernando, Yang Pu, Kendall Morrison, et al.. (2017). Analysis of preclinical and clinical samples after treatment with a CD37 targeting antibody drug conjugate (AGS67E) support a high level of CD37 expression in NHL. Hematological Oncology. 35(S2). 290–291. 1 indexed citations
9.
Morrison, Kendall, Pia M. Challita-Eid, Arthur Raitano, et al.. (2016). Development of ASG-15ME, a Novel Antibody–Drug Conjugate Targeting SLITRK6 , a New Urothelial Cancer Biomarker. Molecular Cancer Therapeutics. 15(6). 1301–1310. 55 indexed citations
10.
Petrylak, Daniel P., Elisabeth I. Heath, Guru Sonpavde, et al.. (2016). Interim analysis of a phase I dose escalation trial of the antibody drug conjugate (ADC) AGS15E (ASG-15ME) in patients (Pts) with metastatic urothelial cancer (mUC). Annals of Oncology. 27. vi269–vi269. 27 indexed citations
11.
Ost, Piet, N. van As, Dominique Pasquier, et al.. (2016). Stereotactic body radiotherapy for nodal oligorecurrent prostate cancer: A multi-institutional analysis. European Urology Supplements. 15(13). e1642–e1643.
12.
Wolpin, Brian M., Eileen M. O’Reilly, Yoo-Joung Ko, et al.. (2013). Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer. Annals of Oncology. 24(7). 1792–1801. 29 indexed citations
13.
Shostak, Yuriy, Suzanne Saïd, Deanna L. Russell, et al.. (2013). Abstract 2047: Discovery and molecular characterization of AGS-15/SLITRK6 as a novel target for antibody-mediated therapeutic development in bladder cancer.. Cancer Research. 73(8_Supplement). 2047–2047. 1 indexed citations
14.
Yang, Peng, Ying Li, Yi Zhang, et al.. (2013). Abstract 1274: SLITRK6, the target of a novel antibody drug conjugate AGS15E, is expressed in bladder and other cancers.. Cancer Research. 73(8_Supplement). 1274–1274. 2 indexed citations
15.
Morrison, Kendall. (2013). Abstract 4332: Development of AGS15E, a novel antibody drug conjugate targeting SLITRK6 for the treatment of bladder cancer.. Cancer Research. 73(8_Supplement). 4332–4332. 1 indexed citations
16.
Challita-Eid, Pia M., Kendall Morrison, Zili An, et al.. (2007). Monoclonal Antibodies to Six-Transmembrane Epithelial Antigen of the Prostate-1 Inhibit Intercellular Communication In vitro and Growth of Human Tumor Xenografts In vivo. Cancer Research. 67(12). 5798–5805. 87 indexed citations
17.
Jakobovits, Aya, Jean Gudas, Xiaofeng Jia, et al.. (2005). Therapeutic potential of AGS-PSCA: A fully human monoclonal antibody to prostate stem cell antigen (PSCA) for the treatment of prostate and pancreatic cancers. Journal of Clinical Oncology. 23(16_suppl). 4722–4722. 7 indexed citations
18.
Myatt, Nyree, G Coghill, Kendall Morrison, David B. Jones, & I A Cree. (1994). Detection of tumour necrosis factor alpha in sarcoidosis and tuberculosis granulomas using in situ hybridisation.. Journal of Clinical Pathology. 47(5). 423–426. 32 indexed citations
19.
Bashir, Muhammed Salman, Kendall Morrison, D H Wright, & David B. Jones. (1992). Alpha-1 antitrypsin gene exon use in stimulated lymphocytes.. Journal of Clinical Pathology. 45(9). 776–780. 2 indexed citations
20.
Jones, David, Kendall Morrison, C Schlüter, et al.. (1990). Tumor necrosis factor alpha and lymphotoxin production in Hodgkin's disease.. PubMed. 137(2). 341–51. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dennis Doleschel Breakdown of academic impact, for papers by Mary‐Keara Boss Breakdown of academic impact, for papers by Gaurav Malviya Breakdown of academic impact, for papers by Fernando López‐Campos Breakdown of academic impact, for papers by Xiumei Ma Breakdown of academic impact, for papers by Nobuhiko Kanaya Breakdown of academic impact, for papers by Marion M. Deken Breakdown of academic impact, for papers by Toru Tamai Breakdown of academic impact, for papers by Denis Beckford-Vera Breakdown of academic impact, for papers by Le-Cun Xu
Rankless by CCL
2026